What does PHARMACIE XAVIER de LEVAL do?

PHARMACIE XAVIER de LEVAL is a pharmacy in Spa. Public Limited, started on 1 January 1987, 2 establishments.

What is the address of PHARMACIE XAVIER de LEVAL?

The registered office of PHARMACIE XAVIER de LEVAL is located at Rue de la Géronstère 12, 4900 Spa.

Is PHARMACIE XAVIER de LEVAL still active?

Yes. According to the CBE (31 October 2026) PHARMACIE XAVIER de LEVAL is active, legal situation “Normale toestand”, started on 1 January 1987.

Is PHARMACIE XAVIER de LEVAL registered on Peppol?

Yes, PHARMACIE XAVIER de LEVAL is registered on the Peppol network with ID 0208:0430678812.

What is the enterprise number of PHARMACIE XAVIER de LEVAL?

The enterprise number of PHARMACIE XAVIER de LEVAL is BE0430678812.

When was PHARMACIE XAVIER de LEVAL founded?

PHARMACIE XAVIER de LEVAL was founded on 1 January 1987.

Who are the directors of PHARMACIE XAVIER de LEVAL?

According to the 2025 annual accounts, the directors of PHARMACIE XAVIER de LEVAL are: Xavier de Leval SRL.

Is PHARMACIE XAVIER de LEVAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1987; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did PHARMACIE XAVIER de LEVAL make in 2025?

PHARMACIE XAVIER de LEVAL posted a profit after taxes of € 60,750 in financial year 2025.

What is the revenue of PHARMACIE XAVIER de LEVAL?

As a small company, PHARMACIE XAVIER de LEVAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 541,517.

How much does an employee at PHARMACIE XAVIER de LEVAL earn?

The average wage cost per full-time employee at PHARMACIE XAVIER de LEVAL was € 55,600 in 2025: staff costs of € 361,524 for 6.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE XAVIER de LEVAL have?

According to the 2025 annual accounts, PHARMACIE XAVIER de LEVAL has 6.5 full-time equivalents (FTE).

PHARMACIE XAVIER de LEVAL (Public Limited) - Spa

Dossier PHARMACIE XAVIER de LEVAL, printed on 31 October 2026 from databakkes.be/en/0430678812/pharmacie-xavier-de-leval. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE XAVIER de LEVAL from Spa, company number BE0430678812, closed financial year 2025 with a result of € 60,750 after tax. For that financial year PHARMACIE XAVIER de LEVAL recorded a gross margin of € 541,517 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 164,239 to € 60,750. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 1.1 million

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 60,750

▼ 63% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 318,125

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,000 paid out

66 % of the profit went to the shareholders, mostly to Xavier de LEVAL (84 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

6.5

▲ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 361,524

▲ 6% vs 2024

€ 55,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 27,781

▼ 59% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 260,203

▼ 26% vs 2024

€ 92,004 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 285,076

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 60,812

▼ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 536,665 Gross margin 2022: € 536,665 First fiscal year in the series	€ 599,555 Gross margin 2023: € 599,555 ▲ 12% vs 2022 (€ 536,665) Favourable step	€ 648,058 Gross margin 2024: € 648,058 ▲ 8% vs 2023 (€ 599,555) Favourable step	€ 541,517 Gross margin 2025: € 541,517 ▼ 16% vs 2024 (€ 648,058) Unfavourable step	▼ 16%
Profit after taxes	€ 158,313 Profit after taxes 2022: € 158,313 First fiscal year in the series	€ 146,274 Profit after taxes 2023: € 146,274 ▼ 8% vs 2022 (€ 158,313) Unfavourable step	€ 164,239 Profit after taxes 2024: € 164,239 ▲ 12% vs 2023 (€ 146,274) Favourable step	€ 60,750 Profit after taxes 2025: € 60,750 ▼ 63% vs 2024 (€ 164,239) Unfavourable step	▼ 63%
Equity	€ 894,401 Equity 2022: € 894,401 First fiscal year in the series	€ 1,000,675 Equity 2023: € 1,000,675 ▲ 12% vs 2022 (€ 894,401) Favourable step	€ 1,089,913 Equity 2024: € 1,089,913 ▲ 9% vs 2023 (€ 1,000,675) Favourable step	€ 1,110,663 Equity 2025: € 1,110,663 ▲ 2% vs 2024 (€ 1,089,913) Favourable step	▲ 2%
Total debts	€ 907,511 Total debts 2022: € 907,511 First fiscal year in the series	€ 908,201 Total debts 2023: € 908,201 Unchanged (€ 907,511) Unfavourable step	€ 888,500 Total debts 2024: € 888,500 ▼ 2% vs 2023 (€ 908,201) Favourable step	€ 656,132 Total debts 2025: € 656,132 ▼ 26% vs 2024 (€ 888,500) Favourable step	▼ 26%
Cash	€ 294,414 Cash 2022: € 294,414 First fiscal year in the series	€ 318,872 Cash 2023: € 318,872 ▲ 8% vs 2022 (€ 294,414) Favourable step	€ 299,206 Cash 2024: € 299,206 ▼ 6% vs 2023 (€ 318,872) Unfavourable step	€ 318,125 Cash 2025: € 318,125 ▲ 6% vs 2024 (€ 299,206) Favourable step	▲ 6%
Retained profit	€ 832,401 Retained profit 2022: € 832,401 First fiscal year in the series	€ 938,675 Retained profit 2023: € 938,675 ▲ 13% vs 2022 (€ 832,401) Favourable step	€ 1,027,913 Retained profit 2024: € 1,027,913 ▲ 10% vs 2023 (€ 938,675) Favourable step	€ 1,048,663 Retained profit 2025: € 1,048,663 ▲ 2% vs 2024 (€ 1,027,913) Favourable step	▲ 2%
Dividend	€ 51,000 Dividend 2022: € 51,000 First fiscal year in the series	€ 40,000 Dividend 2023: € 40,000 ▼ 22% vs 2022 (€ 51,000) Unchanged	€ 75,000 Dividend 2024: € 75,000 ▲ 88% vs 2023 (€ 40,000) Unchanged	€ 40,000 Dividend 2025: € 40,000 ▼ 47% vs 2024 (€ 75,000) Unchanged	▼ 47%
Bank debt	€ 522,183 Bank debt 2022: € 522,183 First fiscal year in the series	€ 514,693 Bank debt 2023: € 514,693 ▼ 1% vs 2022 (€ 522,183) Favourable step	€ 349,767 Bank debt 2024: € 349,767 ▼ 32% vs 2023 (€ 514,693) Favourable step	€ 260,203 Bank debt 2025: € 260,203 ▼ 26% vs 2024 (€ 349,767) Favourable step	▼ 26%
Balance sheet total	€ 1,801,912 Balance sheet total 2022: € 1,801,912 First fiscal year in the series	€ 1,908,876 Balance sheet total 2023: € 1,908,876 ▲ 6% vs 2022 (€ 1,801,912) Unchanged	€ 1,978,413 Balance sheet total 2024: € 1,978,413 ▲ 4% vs 2023 (€ 1,908,876) Unchanged	€ 1,766,795 Balance sheet total 2025: € 1,766,795 ▼ 11% vs 2024 (€ 1,978,413) Unchanged	▼ 11%
Employees (FTE)	5.7 Employees (FTE) 2022: 5.7 First fiscal year in the series	6 Employees (FTE) 2023: 6 ▲ 0.3 vs 2022 (5.7) Unchanged	5.9 Employees (FTE) 2024: 5.9 ▼ 0.1 vs 2023 (6) Unchanged	6.5 Employees (FTE) 2025: 6.5 ▲ 0.6 vs 2024 (5.9) Unchanged	▲ 0.6

Key figures of PHARMACIE XAVIER de LEVAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE XAVIER de LEVAL?

What happened at PHARMACIE XAVIER de LEVAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Xavier de Leval SRL stepped down as director. NBB
Jul 29, 2026 New annual accounts for financial year 2025: profit of € 60,750 (▼ 63% vs 2024). Source: NBB ↗
2024 Xavier de Leval SRL became a director. NBB
Oct 4, 2019 New establishment in Spa. KBO
Apr 2, 1987 New establishment in Spa. KBO
Jan 1, 1987 Start of the company according to the CBE. KBO

In short

From € 158,313 profit in 2022 to € 60,750 profit in 2025.

Paid € 97,611 in corporate taxes since 2022.

Best year ever: 2024, with € 164,239 profit.

On average € 83,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Xavier de LEVAL 84%

MATHILDE KESTEMAN 10%

The stake of Xavier de LEVAL, MATHILDE KESTEMAN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE XAVIER de LEVAL

Pharmacie DEMEUSE 100%

The shares are held by Xavier de LEVAL (84%) and MATHILDE KESTEMAN (10%). It owns 100% of Pharmacie DEMEUSE itself.

Directors

According to the 2025 annual accounts

Xavier de Leval SRL

Director · represented by Xavier de Leval

Also active at: Pharmacie DEMEUSE

since 2024 · until 2030

Shareholders

Xavier de LEVAL

84%

MATHILDE KESTEMAN

10%

Participations

Pharmacie DEMEUSE

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Géronstère 12

4900 Spa

2.298.888.221

Avenue Reine Astrid 1

4900 Spa

Active since 4 October 2019

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Royal Spa Football Club

GROUPE DE LEVAL

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0430.678.812

VAT number

BE 0430.678.812

Registered office

Rue de la Géronstère 12, 4900 Spa

Names & denominations

PHARMACIE XAVIER de LEVAL

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

1 January 1987

Peppol

Active · Active since 18 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE XAVIER de LEVAL

Financials

What happened to PHARMACIE XAVIER de LEVAL?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions